Author:
Ricciuti Biagio,Chiari Rita,Chiarini Pietro,Crinò Lucio,Maiettini Daniele,Ludovini Vienna,Metro Giulio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference8 articles.
1. Metro G, Crinò L. Advances on EGFR mutation for lung cancer. Transl Lung Cancer Res. 2012;1(1):5–13.
2. Metro G, Chiari R, Ricciuti B, et al. Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer. Expert Opin Pharmacother. 2015;16(17):2601–13.
3. Jänne PA, Chih-Hsin J, Kim D-W, et al. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J Med. 2015;372(18):1689–99.
4. Mitsudomi T, Tsai CM, Shepherd FA, et al. AZD9291 in pre-treated T790M positive advanced NSCLC: AURA2 phase II study [abstract]. J Thorac Oncol. 2015;10(9 Suppl 2):S320.
5. Jamal-Hanjani M, Spicer J. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain. Clin Cancer Res. 2012;18:938–44.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献